MedTrace Logo

Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy

NCT02816073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2016-06-29

No results posted yet for this study

Summary

A randomized study to assess the safety and efficacy of single-session pan-retinal photocoagulation (PRP) using Pattern Scan Laser (PASCAL) in proliferative diabetic retinopathy (PDR) - 1,700 shots vs 2,500 shots

Conditions

Interventions

DEVICE

Pan-retinal photocoagulation using pattern scanning laser

Patients receive the designated number of laser shots of pan-retinal photocoagulation with pattern scanning laser in a single session

Sponsors & Collaborators

  • The University of Hong Kong

    collaborator OTHER

  • United Christian Hospital

    lead OTHER

Principal Investigators

  • Kenneth KW Li, MBChB · United Christian Hospital; The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-11-30
Completion
2016-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816073 on ClinicalTrials.gov